PDL BIOPHARMA, INC. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Gain (Loss) on Disposition of Assets
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of convertible notes and term loan offering costs
Accreted interest
Amortization of Intangible Assets
Goodwill, Impairment Loss
Amortization Of Right of Use Assets
Impairment of Intangible Assets, Finite-lived
Asset Impairment Charges
Change in fair value of acquired royalty rights
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount
Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss)
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
Other amortization, depreciation and accretion of embedded derivative
Inventory Write-down
Provision for Doubtful Accounts
Loss on extinguishment of notes receivable
Gains (Losses) on Extinguishment of Debt
Hedge ineffectiveness on foreign exchange contracts
Gain (Loss) on Disposition of Intangible Assets
Gain (Loss) on Sale of Investments
Gain (Loss) on Disposition of Property Plant Equipment
Increase (Decrease) in Other Receivables
Business Combination, Bargain Purchase, Gain Recognized, Amount
Stock-based compensation expense
Deferred taxes
Changes in assets and liabilities:
Receivables from licensees
Increase (Decrease) in Accounts and Other Receivables
Prepaid and other current assets
Accrued interest on notes receivable
Increase (Decrease) in Inventories
Other assets
Accounts payable
Accrued liabilities
Increase (Decrease) in Income Taxes Payable
Increase (Decrease) in Other Deferred Liability
Other long-term liabilities
Net cash provided by operating activities
Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Cash Provided by (Used in) Operating Activities, Discontinued Operations

Cash flows from investing activities
Purchase consideration paid in advance
Purchases of investments
Payments to Acquire Other Investments
Proceeds from Sale and Maturity of Other Investments
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
Maturities of investments
Purchase of royalty rights
Payments for (Proceeds from) Productive Assets
Payments to Acquire Intangible Assets
Proceeds from Sale of Productive Assets
Issuance of notes receivable
Proceeds from Sale and Collection of Notes Receivable
Proceeds from Sale of Intangible Assets
Acquisition of property and equipment
Net cash provided by/(used in) investing activities
Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Cash Provided by (Used in) Investing Activities, Discontinued Operations
Cash flows from financing activities
Proceeds from term loan
Repayments of Unsecured Debt
Cash payment for repurchase of convertible notes
Payments for Repurchase of Convertible Preferred Stock
Repayments of Notes Payable
Payment of debt issuance costs
Net proceeds from the issuance of convertible notes
Purchased call options cost
Other Payments to Acquire Businesses
Payment for Contingent Consideration Liability, Financing Activities
Proceeds from Noncontrolling Interests
Proceeds from issuance of warrants
Cash paid for purchase of noncontrolling interest
Payments for Repurchase of Common Stock
Cash dividends paid
Proceeds from Stock Options Exercised
Excess Tax Benefit from Share-based Compensation, Financing Activities
Net cash used in financing activities

Cash and cash equivalents at beginning of the period
Cash and cash equivalents at end of period
Net Cash Provided by (Used in) Financing Activities, Continuing Operations
Cash Provided by (Used in) Financing Activities, Discontinued Operations
Net increase/(decrease) in cash and cash equivalents
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Supplemental cash flow information
Cash paid for income taxes
Interest Paid, Excluding Capitalized Interest, Operating Activities
Supplemental disclosures of non-cash financing activities
Exchange of debt
Stock Issued
Assets held for sale reclassified from other assets to intangibles
Other Significant Noncash Transaction, Value of Consideration Given
Other Significant Noncash Transaction, Value of Consideration Received
Noncash or Part Noncash Acquisition, Value of Assets Acquired
Noncash or Part Noncash Acquisition, Other Liabilities Assumed
Noncash or Part Noncash Acquisition, Value of Liabilities Assumed
Asset held for sale reclassified from notes receivable to other assets
Extinguishment of Debt, Amount
Dividends, Common Stock, Paid-in-kind

Comments